Identification of micro-organism from positive blood cultures: comparison of three different short culturing methods to the Rapid Sepsityper workflow.


Journal

Journal of medical microbiology
ISSN: 1473-5644
Titre abrégé: J Med Microbiol
Pays: England
ID NLM: 0224131

Informations de publication

Date de publication:
Aug 2022
Historique:
entrez: 5 8 2022
pubmed: 6 8 2022
medline: 10 8 2022
Statut: ppublish

Résumé

Sepsis is one of the leading causes of death worldwide. The rapid identification (ID) of the causative micro-organisms is crucial for the patients' clinical outcome. MALDI-TOF MS has been widely investigated to speed up the time-to-report for ID from positive blood cultures, and many different procedures and protocols were developed, all of them attributable either to the direct separation of microbial cells from the blood cells, or to a short subculture approach. In this study, the Rapid Sepsityper workflow (MBT Sepsityper IVD Kit, Bruker Daltonics GmbH and Co. KG, Bremen, Germany) was compared to three different short subculturing methods, established into the routine practice of three different clinical microbiology laboratories. A total of

Identifiants

pubmed: 35930326
doi: 10.1099/jmm.0.001571
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Arthur B Pranada (AB)

Department of Medical Microbiology, MVZ Dr. Eberhard & Partner Dortmund, Dortmund, Germany.

Miriam Cordovana (M)

Bruker Daltonics GmbH & Co. KG, Bremen, Germany.

Markus Meyer (M)

Bruker Daltonics GmbH & Co. KG, Bremen, Germany.

Hilke Hubert (H)

Bruker Daltonics GmbH & Co. KG, Bremen, Germany.

Mohammad Abdalla (M)

Al Kharj Armed Forces Hospital, Al Kharj, Saudi Arabia.

Simone Ambretti (S)

Operative Unit of Microbiology IRCSS Sant'Orsola, Bologna, Italy.

Joerg Steinmann (J)

Institute for Clinical Hygiene, Medical Microbiology and Infectiology, Klinikum Nürnberg, Paracelsus Medical University, Nürnberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH